0001209191-22-038595.txt : 20220621
0001209191-22-038595.hdr.sgml : 20220621
20220621204852
ACCESSION NUMBER: 0001209191-22-038595
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220616
FILED AS OF DATE: 20220621
DATE AS OF CHANGE: 20220621
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MCMANUS MICHAEL A JR
CENTRAL INDEX KEY: 0001051997
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26770
FILM NUMBER: 221029751
MAIL ADDRESS:
STREET 1: 241-02 NORTHERN BLVD
CITY: DOUGLASTON
STATE: NY
ZIP: 11362
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NOVAVAX INC
CENTRAL INDEX KEY: 0001000694
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 222816046
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21 FIRSTFIELD ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
BUSINESS PHONE: 240-268-2000
MAIL ADDRESS:
STREET 1: 21 FIRSTFIELD ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-06-16
0
0001000694
NOVAVAX INC
NVAX
0001051997
MCMANUS MICHAEL A JR
C/O NOVAVAX, INC.
21 FIRSTFIELD ROAD
GAITHERSBURG
MD
20878
1
0
0
0
Common Stock
2022-06-16
4
M
0
700
A
10101
D
Restricted Stock Units
2022-06-16
4
M
0
700
0.00
D
Common Stock
700
0
D
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.
In connection with the reporting person's departure from the Board of Directors (the "Board"), the Board accelerated the vesting of 700 RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended (the "Plan"), to June 16, 2022 from June 17, 2022.
/s/ John A. Herrmann III, Attorney-in-Fact
2022-06-21